Zobrazeno 1 - 10
of 120
pro vyhledávání: '"Sabine, Gerull"'
Autor:
Caroline Arber, Gabriela Baerlocher, Yves Chalandon, Michael Daskalakis, Michel Duchosal, Martin Fehr, Sabine Gerull, Tayfun Güngör, Gayathri Nair, Thomas Pabst, Jakob R. Passweg, Barbara Piccolruaz, Christoph Renner, Axel Ruefer, Dominik Schneidawind, Georg Stüssi, Sacha Zeerleder, Jörg P. Halter
Publikováno v:
Swiss Medical Weekly, Vol 154, Iss 10 (2024)
No abstract available.
Externí odkaz:
https://doaj.org/article/1a08507158c34aa0be6c05c66d9e61ff
Autor:
Sabina De Geest, Sabine Valenta, Janette Ribaut, Sabine Gerull, Juliane Mielke, Michael Simon, Jana Bartakova, Klaus Kaier, Jens Eckstein, Lynn Leppla, Alexandra Teynor, on behalf of the SMILe team
Publikováno v:
BMC Health Services Research, Vol 22, Iss 1, Pp 1-20 (2022)
Abstract Background While effectiveness outcomes of eHealth-facilitated integrated care models (eICMs) in transplant and oncological populations are promising, implementing and sustaining them in real-world settings remain challenging. Allogeneic ste
Externí odkaz:
https://doaj.org/article/3b97e091537047c49511cedad27633ea
Autor:
Kimmo Weisshaar, Hannah Ewald, Jörg Halter, Sabine Gerull, Sandra Schönfeld, Yuliya Senft, Maria Martinez, Anne Leuppi-Taegtmeyer, Nina Khanna, Birgit Maier, Antonio Risitano, Regis Peffault de Latour, Andre Tichelli, Jakob Passweg, Beatrice Drexler
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 15, Iss 1, Pp 1-12 (2020)
Abstract Background The introduction of new therapy modalities has significantly improved the outcome of aplastic anemia (AA) and paroxysmal nocturnal hemoglobinuria (PNH) patients. However, relatively little is known about the exact disease burden o
Externí odkaz:
https://doaj.org/article/3c7323744051426f8f43ff6b8f020f14
Autor:
Adalgisa Condoluci, Marie Théaudin, Rahel Schwotzer, Aju P. Pazhenkottil, Paolo Arosio, Manuela Averaimo, Ulrike Bacher, Peter Bode, Andrea Cavalli, Stefan Dirnhofer, Nadia Djerbi, Stephan Dobner, Thomas Fehr, Maura Garofalo, Ariana Gaspert, Sabine Gerull, Raphael Heimgartner, Annemarie Hübers, Hans H. Jung, Chiara Kessler, Raphael Knöpfel, Natallia Laptseva, Giulia Magini, Robert Manka, Luca Mazzucchelli, Martin Meyer, Violeta Mihaylova, Pierre Monney, Alessio Mylonas, René Nkoulou, Thomas Pabst, Otmar Pfister, Axel Rüfer, Adrian Schmidt, Harald Seeger, Simon F. Stämpfli, Guido Stirnimann, Thomas Suter, Giorgio Treglia, Alexandar Tzankov, Friederike Vetter, Markus Zweier, Andreas J. Flammer, Bernhard Gerber
Publikováno v:
Swiss Medical Weekly, Vol 151, Iss 4142 (2021)
This article was corrected and republished online on November 4, 2021. Please see Erratum (Swiss Med Wkly. 2021;151:w30104)
Externí odkaz:
https://doaj.org/article/a2cc0239496a4b7e934b23762969b699
Autor:
Rahel Schwotzer, Andreas J. Flammer, Sabine Gerull, Thomas Pabst, Paolo Arosio, Manuela Averaimo, Ulrike Bacher, Peter Bode, Andrea Cavalli, Adalgisa Condoluci, Stefan Dirnhofer, Nadia Djerbi, Stephan W. Dobner, Thomas Fehr, Maura Garofalo, Ariana Gaspert, Raphael Heimgartner, Annemarie Hübers, Hans H. Jung, Chiara Kessler, Raphael Knöpfel, Natallia Laptseva, Robert Manka, Luca Mazzucchelli, Martin Meyer, Violeta Mihaylova, Pierre Monney, Alessio Mylonas, René Nkoulou, Aju P. Pazhenkottil, Otmar Pfister, Axel Rüfer, Adrian Schmidt, Harald Seeger, Simon F. Stämpfli, Guido Stirnimann, Thomas Suter, Marie Théaudin, Giorgio Treglia, Alexandar Tzankov, Friederike Vetter, Markus Zweier, Bernhard Gerber
Publikováno v:
Swiss Medical Weekly, Vol 150, Iss 4950 (2020)
Systemic amyloidosis is a heterogeneous group of diseases associated with protein misfolding into insoluble beta-sheet rich structures that deposit extracellularly in different organs, eventually compromising their function. There are more than 30 di
Externí odkaz:
https://doaj.org/article/0e5c75901fcc4911aff0d76ae3910380
Autor:
Guacimara Ortega Sanchez, Frank Stenner, Stefan Dirnhofer, Jakob Passweg, Sabine Gerull, Jörg P. Halter, Alfred Zippelius, Heinz Läubli
Publikováno v:
Swiss Medical Weekly, Vol 149, Iss 4546 (2019)
Cancer immunotherapy with immune checkpoint inhibitors (ICIs) such as programmed death ligand-1 (PD-L1) blockers offers pronounced clinical benefit with durable responses and a manageable safety profile. Patients with a high risk of immune-related ad
Externí odkaz:
https://doaj.org/article/f5f4da1eac9d4308a4014910d0b20e43
Autor:
Ali Bazarbachi, Myriam Labopin, Giorgia Battipaglia, Azedine Djabali, Edouard Forcade, William Arcese, Gerard Socié, Didier Blaise, Joerg Halter, Sabine Gerull, Jan J. Cornelissen, Patrice Chevallier, Johan Maertens, Nicolaas Schaap, Jean El-Cheikh, Jordi Esteve, Arnon Nagler, Mohamad Mohty
Publikováno v:
Clinical Hematology International, Vol 1, Iss 1 (2019)
Acute myeloid leukemia (AML) with FLT3-mutation carries a poor prognosis, and allogeneic stem cell transplantation (allo-SCT) is recommended at first complete remission (CR1). We assessed 462 adults (median age 50 years) with FLT3-mutated AML allogra
Externí odkaz:
https://doaj.org/article/c9a29716c8ef47a3af4bed4397b0c8d7
Autor:
Silas Bänziger, Kimmo Weisshaar, Reetta Arokoski, Sabine Gerull, Jörg Halter, Alicia Rovó, Mario Bargetzi, Jeroen S. Goede, Yuliya Senft, Sabine Valenta, Jakob R. Passweg, Beatrice Drexler
Publikováno v:
Bänziger, Silas; Weisshaar, Kimmo; Arokoski, Reetta; Gerull, Sabine; Halter, Jörg; Rovó, Alicia; Bargetzi, Mario; Goede, Jeroen S; Senft, Yuliya; Valenta, Sabine; Passweg, Jakob R; Drexler, Beatrice (2023). Feasibility of electronic patient-reported outcome monitoring and self-management program in aplastic anemia and paroxysmal nocturnal hemoglobinuria-a pilot study (ePRO-AA-PNH). Annals of hematology, 102(1), pp. 199-208. Springer-Verlag 10.1007/s00277-022-05012-5
Introduction Electronic patient-reported outcomes (ePRO) are increasingly recognized in health care, as they have been demonstrated to improve patient outcomes in cancer, but have been less studied in rare hematological diseases. The aim of this stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdd8c331067a6476d49469fce08b891e
https://boris.unibe.ch/174489/1/s00277-022-05012-5.pdf
https://boris.unibe.ch/174489/1/s00277-022-05012-5.pdf
Autor:
Jakob R. Passweg, Helen Baldomero, Marc Ansari, Gabriela M. Baerlocher, Mario Bargetzi, Yves Chalandon, Michel A. Duchosal, Sabine Gerull, Tayfun Güngör, Jörg P. Halter, Dominik Heim, Urs Hess, Kurt Leibundgut, Stavroula Masouridi-Levrat, Antonia Müller, Gayathri Nair, Thomas Pabst, Christoph Renner, Adrian Schmidt, Georg Stussi, Grazia Nicoloso de Faveri, Urs Schanz, for the Swiss Blood Stem Cell Transplantation Group (SBST)
Publikováno v:
Swiss Medical Weekly, Vol 148, Iss 0910 (2018)
In 1997, the Swiss Blood Stem Cell Transplantation Group (SBST) initiated a mandatory national registry for all haematopoietic stem cell transplants (HCTs) in Switzerland. As of 2016, after 20 years, information was available for 7899 patients who ha
Externí odkaz:
https://doaj.org/article/c36c8bd0307b48e194437f606e771da4
Autor:
Maja Weisser, Mihaela Sava, Veronika Baettig, Sabine Gerull, Jakob Passweg, Nina Khanna, Christian Garzoni, Bernhard Gerber, Nicolas Mueller, Urs Schanz, Christoph Berger, Yves Chalandon, Christian van Delden, Dionysios Neofytos, Susanne Stampf, Fabian Franzeck
Empiric antibiotic treatment for bloodstream infection (BSI) after haematopoietic cell transplantation (HCT) in the era of antimicrobial resistance is challenging. We conducted a nested project in the Swiss Transplant Cohort Study 09/2009 to 10/2018
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bcc93713ab927c278b1bcdfb8ead6660
https://doi.org/10.21203/rs.3.rs-1828291/v1
https://doi.org/10.21203/rs.3.rs-1828291/v1